Background and objectivesTo simulate the cost-effectiveness of Mesenchymal Stromal Cell (MSC) therapy compared to sodium/glucose co-transporter 2 inhibitors (SGLT2i) or usual care (UC) in treating patients with Diabetic Kidney Disease (DKD). Design. setting. participants. https://www.ngetikin.com/limited-value-Sapatilha-Infantil-Pampili-Bailarina-Laco-Duplo-Glitter-Prata-great-pick/